| 000 | 01748 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517153727.0 | ||
| 264 | 0 | _c20180418 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1559-0755 | ||
| 024 | 7 |
_a10.1007/s12026-017-8927-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Mao | |
| 245 | 0 | 0 |
_aClinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bImmunologic research _c08 2017 |
||
| 300 |
_a880-887 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _ximmunology |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCryosurgery |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
| 650 | 0 | 4 |
_aIsoantigens _ximmunology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 |
_aLung Neoplasms _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLiang, Shu-Zhen | |
| 700 | 1 | _aWang, Xiao-Hua | |
| 700 | 1 | _aLiang, Ying-Qing | |
| 700 | 1 | _aZhang, Ming-Jie | |
| 700 | 1 | _aNiu, Li-Zhi | |
| 700 | 1 | _aChen, Ji-Bing | |
| 700 | 1 | _aLi, Hai-Bo | |
| 700 | 1 | _aXu, Ke-Cheng | |
| 773 | 0 |
_tImmunologic research _gvol. 65 _gno. 4 _gp. 880-887 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12026-017-8927-x _zAvailable from publisher's website |
| 999 |
_c27177991 _d27177991 |
||